Treatment of enterocutaneous fistula: a systematic review and meta-analysis.
Enterocutaneous fistula
Meta-analysis
Postoperative
Small bowel
Surgery
Systematic review
Journal
Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
08
04
2022
accepted:
20
06
2022
pubmed:
2
8
2022
medline:
1
10
2022
entrez:
1
8
2022
Statut:
ppublish
Résumé
Enterocutaneous fistula (ECF) is an abnormal communication between the gastrointestinal tract and skin, with a myriad of etiologies and therapeutic options. Management is influenced by etiology and specifics of the ECF, and patient-related factors. The aim of this study was to assess overall success, recurrence, and mortality rates of treatment for ECF. A systematic search of PubMed and Google Scholar was performed through October 2021 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Case reports, reviews, animal studies, studies not reporting outcomes, had no available English text, included patients < 16 years old or those assessing other abdominocutaneous/internal fistulas were excluded. Fifty-three studies, between 1975 and 2020, incorporating 3078 patients were included. Patient age ranged between 16 and 87 years with a male:female ratio of 1.14:1. ECF developed postoperatively in 89.4%. Other common etiologies were inflammatory bowel disease, trauma, malignancy, and radiation. At least 28% of patients had complex fistulae (reported in 18 studies). Most common fistula site was small bowel. In 34 publications, 62.4% (n = 1371) patients received parenteral nutrition. In 45 publications, 72.5% underwent surgery to treat the fistula. Meta-analysis revealed an 89% healing rate; recurrence rate after initial successful treatment was 11.1%, and mortality rate was 8.5%. In a subgroup of patients who underwent combined ECF takedown and abdominal wall reconstructions (n = 315), 78% achieved fascial closure, mesh was used in 72%, hernia, and fistula recurrence rates were 19.7% and 7.6%, respectively. Treatment of ECF must be individualized according to specific etiology and location of the fistula and the patient's associated conditions.
Sections du résumé
BACKGROUND
Enterocutaneous fistula (ECF) is an abnormal communication between the gastrointestinal tract and skin, with a myriad of etiologies and therapeutic options. Management is influenced by etiology and specifics of the ECF, and patient-related factors. The aim of this study was to assess overall success, recurrence, and mortality rates of treatment for ECF.
MATERIALS
A systematic search of PubMed and Google Scholar was performed through October 2021 according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Case reports, reviews, animal studies, studies not reporting outcomes, had no available English text, included patients < 16 years old or those assessing other abdominocutaneous/internal fistulas were excluded.
RESULTS
Fifty-three studies, between 1975 and 2020, incorporating 3078 patients were included. Patient age ranged between 16 and 87 years with a male:female ratio of 1.14:1. ECF developed postoperatively in 89.4%. Other common etiologies were inflammatory bowel disease, trauma, malignancy, and radiation. At least 28% of patients had complex fistulae (reported in 18 studies). Most common fistula site was small bowel. In 34 publications, 62.4% (n = 1371) patients received parenteral nutrition. In 45 publications, 72.5% underwent surgery to treat the fistula. Meta-analysis revealed an 89% healing rate; recurrence rate after initial successful treatment was 11.1%, and mortality rate was 8.5%. In a subgroup of patients who underwent combined ECF takedown and abdominal wall reconstructions (n = 315), 78% achieved fascial closure, mesh was used in 72%, hernia, and fistula recurrence rates were 19.7% and 7.6%, respectively.
CONCLUSIONS
Treatment of ECF must be individualized according to specific etiology and location of the fistula and the patient's associated conditions.
Identifiants
pubmed: 35915291
doi: 10.1007/s10151-022-02656-3
pii: 10.1007/s10151-022-02656-3
doi:
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
863-874Informations de copyright
© 2022. Springer Nature Switzerland AG.
Références
Edmunds LH Jr, Williams GM, Welch CE (1960) External fistulas arising from the gastro-intestinal tract. Ann Surg 152(3):445–471
pubmed: 13725742
pmcid: 1613656
doi: 10.1097/00000658-196009000-00009
Fischer JE (1983) The pathophysiology of enterocutaneous fistulas. World J Surg 7(4):446–450
pubmed: 6414189
doi: 10.1007/BF01655932
Lundy JB, Fischer JE (2010) Historical perspectives in the care of patients with enterocutaneous fistula. Clin Colon Rectal Surg 23(3):133–141
pubmed: 21886462
pmcid: 2967312
doi: 10.1055/s-0030-1262980
Visschers RG, Olde Damink SW, Winkens B, Soeters PB, van Gemert WG (2008) Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg 32(3):445–453
pubmed: 18175171
pmcid: 2248608
doi: 10.1007/s00268-007-9371-1
Lauro A, Cirocchi R, Cautero N et al (2017) Surgery for post-operative entero-cutaneous fistulas: is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature. G Chir 38(4):185–198
pubmed: 29182901
pmcid: 5725163
doi: 10.11138/gchir/2017.38.4.185
Draus JM Jr, Huss SA, Harty NJ, Cheadle WG, Larson GM (2006) Enterocutaneous fistula: are treatments improving? Surgery 140(4):570–576
pubmed: 17011904
doi: 10.1016/j.surg.2006.07.003
Redden MH, Ramsay P, Humphries T, Fuhrman GM (2013) The etiology of enterocutaneous fistula predicts outcome. Ochsner J 13(4):507–511
pubmed: 24357998
pmcid: 3865828
Ortiz LA, Zhang B, McCarthy MW et al (2017) Treatment of enterocutaneous fistulas, then and now. Nutr Clin Pract 32(4):508–515
pubmed: 28358595
doi: 10.1177/0884533617701402
Martinez JL, Luque-de-Leon E, Mier J, Blanco-Benavides R, Robledo F (2008) Systematic management of postoperative enterocutaneous fistulas: factors related to outcomes. World J Surg 32(3):436–443 (discussion 444)
pubmed: 18057983
doi: 10.1007/s00268-007-9304-z
Martinez JL, Luque-de-León E, Ballinas-Oseguera G et al (2012) Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula. J Gastrointest Surg 16(1):156–163 (discussion 163-164)
pubmed: 22002412
doi: 10.1007/s11605-011-1703-7
Owen RM, Love TP, Perez SD et al (2013) Definitive surgical treatment of enterocutaneous fistula: outcomes of a 23-year experience. JAMA Surg 148(2):118–126
pubmed: 23560282
doi: 10.1001/2013.jamasurg.153
Brenner M, Clayton JL, Tillou A, Hiatt JR, Cryer HG (2009) Risk factors for recurrence after repair of enterocutaneous fistula. Arch Surg 144(6):500–505
pubmed: 19528379
doi: 10.1001/archsurg.2009.66
Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71
pubmed: 33782057
pmcid: 8005924
doi: 10.1136/bmj.n71
Sterne JA, Hernán MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:4919
doi: 10.1136/bmj.i4919
Oxford Centre for Evidence-Based Medicine OCEBM Levels of Evidence Working Group (2021). “The Oxford Levels of Evidence 2” [(accessed on 11 Nov 2021)]; Available online: https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
Langkamp-Henken B (2003) If the gut works, use it: but what if you can’t? Nutr Clin Pract 18(6):449–450
pubmed: 16215080
doi: 10.1177/0115426503018006449
Datta V, Engledow A, Chan S, Forbes A, Cohen CR, Windsor A (2010) The management of enterocutaneous fistula in a regional unit in the United Kingdom: a prospective study. Dis Colon Rectum 53(2):192–199
pubmed: 20087095
doi: 10.1007/DCR.0b013e3181b4c34a
Fischer PE, Fabian TC, Magnotti LJ et al (2009) A ten-year review of enterocutaneous fistulas after laparotomy for trauma. J Trauma 67(5):924–928
pubmed: 19901649
Ravindran P, Ansari N, Young CJ, Solomon MJ (2014) Definitive surgical closure of enterocutaneous fistula: outcome and factors predictive of increased postoperative morbidity. Colorectal Dis 16:209–218
pubmed: 24521276
doi: 10.1111/codi.12473
Hollington P, Mawdsley J, Lim W, Gabe SM, Forbes A, Windsor AJ (2004) An 11-year experience of enterocutaneous fistula. Br J Surg 91(12):1646–1651
pubmed: 15505866
doi: 10.1002/bjs.4788
McIntyre PB, Ritchie JK, Hawley PR, Bartram CI, Lennard-Jones JE (1984) Management of enterocutaneous fistulas: a review of 132 cases. Br J Surg 71(4):293–296
pubmed: 6423028
doi: 10.1002/bjs.1800710416
Lynch AC, Delaney CP, Senagore AJ, Connor JT, Remzi FH, Fazio VW (2004) Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery. Ann Surg 240(5):825–831
pubmed: 15492564
pmcid: 1356488
doi: 10.1097/01.sla.0000143895.17811.e3
Hodgkinson JD, Maeda Y, Leo CA, Warusavitarne J, Vaizey CJ (2017) Complex abdominal wall reconstruction in the setting of active infection and contamination: a systematic review of hernia and fistula recurrence rates. Colorectal Dis 19(4):319–330
pubmed: 28102927
doi: 10.1111/codi.13609
Martinez JL, Souza-Gallardo LM, Ferat-Osorio E (2020) The importance of abdominal wall closure after definitive surgery for enterocutaneous fistula. World J Surg 44:3333–3340
pubmed: 32556420
doi: 10.1007/s00268-020-05635-7
Kanters AE, Krpata DM, Blatnik JA, Novitsky YM, Rosen MJ (2012) Modified hernia grading scale to stratify surgical site occurrence after open ventral hernia repairs. J Am Coll Surg 215(6):787–793
pubmed: 22999328
doi: 10.1016/j.jamcollsurg.2012.08.012
Klifto KM, Othman S, Messa CA, Piwnica-Worms W, Fischer JP, Kovach SJ (2021) Risk factors, outcomes, and complications associated with combined ventral hernia and enterocutaneous fistula single-staged abdominal wall reconstruction. Hernia 25(6):1537–1548
pubmed: 33538927
doi: 10.1007/s10029-021-02371-2
Abdulmughni Y, Saleh AM, Al-Eryani R, Al-Hureibi K (2014) Evaluation of the outcome of conservative treatment of enterocutaneous fistulae (an optimistic result): 48 Model Hospital, Sanna’a, Yemen. Suez Canal Univ Med J 17(2):141–144
doi: 10.21608/scumj.2014.46788
Akhtar N, Shahzad MA, Ul Hassan SS, Racheed U, Ullah S, Sabir M (2020) Frequency of spontaneous closure of post- operative Enterocutaneous fistula. Prof Med J. https://doi.org/10.29309/TPMJ/2020.27.09.3978
doi: 10.29309/TPMJ/2020.27.09.3978
Badrasawi MM, Shahar S, Sagap I (2014) Nutritional management of enterocutaneous fistula: a retrospective study at a Malaysian university medical center. J Multidiscip Healthc 7:365–370
pubmed: 25187726
pmcid: 4149450
Berro A, Silvia S, Costea D et al (2014) The challenge of enterocutaneous fistulae. ARS Medica Tomitana 3(78):123–128
Borison DI, Bloom AD, Pritchard TJ (1992) Treatment of enterocutaneous and colocutaneous fistulas with early surgery or somatostatin analog. Dis Colon Rectum 35(7):635–639
pubmed: 1351835
doi: 10.1007/BF02053752
Fafaj A, Tastaldi L, Alkhatib H et al (2021) Management of ventral hernia defect during enterocutaneous fistula takedown: practice patterns and short-term outcomes from the Abdominal Core Health Quality Collaborative. Hernia 25(4):1013–1020
pubmed: 33389276
doi: 10.1007/s10029-020-02347-8
Smith TA, Hardman RL, Jenkins L, Marashi K, O’Hara R, Cizman Z (2021) Extracellular matrix enterocutaneous fistula plugs show promise for low-flow colocutaneous and enterocutaneous fistulae. J Vasc Interv Radiol 32(1):128–134
pubmed: 33229185
doi: 10.1016/j.jvir.2020.08.033
Gyorki DE, Brooks CE, Gett R et al (2010) Enterocutaneous fistula: a single-centre experience. ANZ J Surg 80(3):178–181
pubmed: 20575922
doi: 10.1111/j.1445-2197.2009.05086.x
Hugh TB, Coleman MJ, Cohen A (1986) Persistent postoperative enterocutaneous fistula: pathophysiology and treatment. Aust N Z J Surg 56(12):901–906
pubmed: 3469983
doi: 10.1111/j.1445-2197.1986.tb01852.x
Hwang TL, Chen MF (1995) Randomized trial of fibrin tissue glue for low output enterocutaneous fistula. Br J Surg 83(1):112
doi: 10.1002/bjs.1800830135
Khan S, Oonwala Z (2002) Enterocutaneous fistula. J Surg Pak (Int) 7(1):27
Krpata DM, Stein SL, Eston M, et al (2013). Outcomes of simultaneous large complex abdominal wall reconstruction and enterocutaneous fistula takedown. Am J Surg. 205(3):354–358; discussion 358–9.
Kumar P, Maroju NK, Kate V (2011) Enterocutaneous fistulae: etiology, treatment, and outcome—a study from South India. Saudi J Gastroenterol 117(6):391–395
Leang YJ, Bell SW, Carne P et al (2018) Enterocutaneous fistula: analysis of clinical outcomes from a single Victorian tertiary referral centre. ANZ J Surg 88(1–2):E30–E33
pubmed: 27452814
doi: 10.1111/ans.13686
Medeiros AC, Aires-Neto T, Marchini JS, Brandão-Neto J, Valença DM, Egito ES (2004) Treatment of postoperative enterocutaneous fistulas by high-pressure vacuum with a normal oral diet. Dig Surg 21(5–6):401–405
pubmed: 15564785
doi: 10.1159/000082317
Murphy J, Hotouras A, Koers L, Bhan C, Glynn M, Chan CL (2013) Establishing a regional enterocutaneous fistula service: the Royal London hospital experience. Int J Surg 11(9):952–956
pubmed: 23796446
doi: 10.1016/j.ijsu.2013.06.011
Garale MN, Takalkar YP, Venkatramani K (2017) Clinical study of Enterocutaneous fistula. Int Surg J 4(9):2972–2976
doi: 10.18203/2349-2902.isj20173705
Noori IF (2021) Postoperative enterocutaneous fistulas: management outcomes in 23 consecutive patients. Ann Med Surg (Lond) 66:102413
doi: 10.1016/j.amsu.2021.102413
Pruimboom T, Ploegmakers IBM, Bijkerk E, Breukink SO, van der Hulst RRWJ, Qiu SS (2021) Fasciocutaneous anterolateral thigh flaps for complex abdominal wall reconstruction after resection of enterocutaneous fistulas and the role of indocyanine green angiography: a pilot study. Hernia 25(2):321–329
pubmed: 32219573
doi: 10.1007/s10029-020-02167-w
Sharma DC, Jalendra G, Kumar PMA (2020) Outcome and management of postoperative enterocutaneous fistula Outcome and management of postoperative enterocutaneous fistula. Int Surg J 7(12):4112–4115
doi: 10.18203/2349-2902.isj20205365
Surriah MH, Bakkour AM, Hassan AN (2019) Management and outcome of patients with gastrointestinal cutaneous fistula in Al-Karama teaching hospital. Int Surg J 6(1):92–97
doi: 10.18203/2349-2902.isj20185134
Taggarshe D, Bakston D, Jacobs M, McKendrick A, Mittal VK (2010) Management of enterocutaneous fistulae: a 10 years experience. World J Gastrointest Surg 2(7):242–246
pubmed: 21160881
pmcid: 2999248
doi: 10.4240/wjgs.v2.i7.242
Valle SJ, Alzahrani N, Alzahrani S, Traiki TB, Liauw W, Morris DL (2016) Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes. Surg Oncol 25(3):315–320
pubmed: 27566038
doi: 10.1016/j.suronc.2016.05.025
Visschers RGJ, van Gemert WG, Winkens B et al (2012) Guided treatment improves outcome of patients with enterocutaneous fistulas. World J Surg 36:2341–2348
pubmed: 22669399
pmcid: 3465546
doi: 10.1007/s00268-012-1663-4
Yan D, Ren J, Wang G, Liu S, Li J (2014) Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn’s disease. Eur J Clin Nutr 68(8):959–963
pubmed: 24619104
doi: 10.1038/ejcn.2014.31
Young S, D’Souza D, Hunter D, Golzarian J, Rosenberg M (2017) The use of latex catheters to close enterocutaneous fistulas: an institutional protocol and retrospective review. AJR Am J Roentgenol 208(6):1373–1377
pubmed: 28301212
doi: 10.2214/AJR.16.17294
Xhaja X, Church J (2013) Enterocutaneous fistulae in familial adenomatous polyposis patients with abdominal desmoid disease. Colorectal Dis 15(10):1238–1242
pubmed: 23819848
doi: 10.1111/codi.12334
Roy J, Sims K, Rider P, Grimm L, Hunter J, Richards W (2019) Endoscopic technique for closure of enterocutaneous fistulas. Surg Endosc 33(10):3464–3468
pubmed: 30652194
doi: 10.1007/s00464-018-06646-1
Amiot A, Setakhr V, Seksik P et al (2014) Long-term outcome of enterocutaneous fistula in patients with Crohn’s disease treated with anti-TNF therapy: a cohort study from the GETAID. Am J Gastroenterol 109(9):1443–1449
pubmed: 25091063
doi: 10.1038/ajg.2014.183
Alvarez C, McFadden DW, Reber HA (2000) Complicated enterocutaneous fistulas: failure of octreotide to improve healing. World J Surg 24(5):533–537
pubmed: 10787072
doi: 10.1007/s002689910086
Taner T, Cima RR, Larson DW, Dozois EJ, Pemberton JH, Wolff BG (2009) Surgical treatment of complex enterocutaneous fistulas in IBD patients using human acellular dermal matrix. Inflamm Bowel Dis 15(8):1208–1212
pubmed: 19170192
doi: 10.1002/ibd.20882
Adabi K, Manrique OJ, Vijayasekaran A et al (2020) Combined single-stage enterolysis with pedicle seromuscular bowel flaps, myocutaneous and fasciocutaneous flaps to repair recurrent enterocutaneous fistulas in complex abdominal Wall defects. Microsurgery 40(1):19–24
pubmed: 30178520
doi: 10.1002/micr.30374
Allardyce DB (1983) Management of small bowel fistulas. Am J Surg 145(5):593–595
pubmed: 6405645
doi: 10.1016/0002-9610(83)90099-5
Slater NJ, Bokkerink WJ, Konijn V, Bleichrodt RP, van Goor H (2015) Safety and durability of one-stage repair of abdominal wall defects with enteric fistulas. Ann Surg 261(3):553–557
pubmed: 24950273
doi: 10.1097/SLA.0000000000000733
Hill GL, Bambach CP (1981) A technique for the operative closure of persistent external small-bowel fistulas. Aust N Z J Surg 51(5):477–485
pubmed: 6459080
doi: 10.1111/j.1445-2197.1981.tb05990.x
Gupta M, Sonar P, Kakodkar R et al (2008) Small bowel enterocutaneous fistulae: the merits of early surgery. Indian J Surg 70(6):303–307
pubmed: 23133088
pmcid: 3452362
doi: 10.1007/s12262-008-0087-8
Chaudhry R (2004) The challenge of enterocutaneous fistulae. Med J Armed Forces India 60(3):235–238
pubmed: 27407640
pmcid: 4923209
doi: 10.1016/S0377-1237(04)80053-4